Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4214)

Showing 12 of 4214 View All
Showing 227 of 352 pages

How Gavi, UNICEF and WHO supported Timor-Leste’s successful COVID-19 response strategy

Timor Leste has kept COVID-19 infections to a minimum, and thanks to effective collaboration has managed to successfully reverse the initial declines seen in immunisation coverage and health service delivery.

Q&A with Dr Odete

Timor-Leste’s Director-General of Health Services for the Ministry of Health discusses the unique challenges of tackling COVID-19 in Timor-Leste and how have they been addressed.

Strengthening supply chains: a long-term investment

The Vaccine Alliance has been working hard in recent years to build greater resilience in supply chains, an effort that is starting to show results.

Why we need a “portfolio approach” to COVID-19 vaccine development

Most vaccine candidates in early development fail: this is the stark reality of vaccine development.

Children who get zero vaccines deserve 100% of our attention

Over 50% more children were immunised in Gavi countries in 2019 than in 2000, yet 10.6 million children continue to miss out entirely on basic vaccinations. Here’s why reaching these children and setting them on the pathway to full immunisation…

Once we have effective Covid-19 treatments, it shouldn’t only be the rich who benefit

We need a range of treatments to make Covid-19 preventable and treatable. Jeremy Farrar describes recent progress made by research and why more investment is needed.

Boosting demand for immunisation

Building and maintaining demand for immunisation is an integral part of Gavi’s work to increase coverage and equity. Here’s an insight into how we have achieved this.

Brazil city ‘might have reached herd immunity'

Herd immunity threshold may have been reached in Amazonas capital, Manaus, but experts warn that herd immunity is not the end of the pandemic.

Why some people might be immune to certain COVID-19 vaccines

Vaccines based on the common cold virus are at the forefront of the COVID-19 vaccine race, but they may be less effective in people who have previously been infected by these common pathogens. So how could we overcome this challenge?

Gavi receives 2020 Princess of Asturias Award for International Cooperation

Gavi recognised for facilitating universal access to vaccines to reduce the impact of infectious diseases and contributing to the protection of half of the global child population through vaccination.

How innovative finance can fight deadly diseases

One of the vital components to Gavi’s capital structure is the International Finance Facility for Immunisation (IFFIm). A powerful and award-winning financial tool launched in 2006, IFFIm issues Vaccine Bonds on the capital markets against long-…

Why handwashing with soap is the most effective way to stop viruses

Global Handwashing Day and the ongoing spread of COVID-19 is a timely reminder about the importance of handwashing with soap as an effective and affordable way to stay healthy.

Subscribe to our newsletter